EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Degradation of Cyclin-Dependent Kinase: A New Weapon for Cancer Therapy

Xing Tian, Xiaojie Dai, Ye Zhong, Maosheng Cheng, Yang Liu

Pharmaceutical Fronts · 01.12.2025 · 07 (04) · e275-e293

DOI: 10.1055/a-2742-7859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Fronts, erschienen am 01.12.2025. Verfasst von Xing Tian und 4 weiteren Autor:innen. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liaoning Innovative Talents in University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting cyclin-dependent kinase (CDK) families is a promising strategy for cancer therapy due to the close association between CDKs and an abnormal cell cycle or transcriptional regulation. However, after extensive clinical use, small molecule inhibitors of CDKs have also exposed issues, such as off-target effects or acquired drug resistance. Targeting protein degradation technology, which has been validated to be effective for many targets, has undergone more than 20 years of development, and some of these methods have been pushed into clinical trials. In this review, we summarized some successful reports on CDK-targeted degradation during recent years. Moreover, some challenging issues and future development trends are highlighted in the prospect section, which might provide updated insight into the development of novel CDK-targeted degraders with great potential as a new weapon for cancer therapy.

Förderung

  • Liaoning Innovative Talents in University

Zitieren

APA

Tian, X., Dai, X., Zhong, Y., Cheng, M., & Liu, Y. (2025). Degradation of Cyclin-Dependent Kinase: A New Weapon for Cancer Therapy. Pharmaceutical Fronts, 07(04), e275-e293. https://doi.org/10.1055/a-2742-7859

Vancouver

Tian X, Dai X, Zhong Y, Cheng M, Liu Y. Degradation of Cyclin-Dependent Kinase: A New Weapon for Cancer Therapy. Pharmaceutical Fronts. 2025;07(04):e275-e293. doi:10.1055/a-2742-7859

BibTeX
@article{Tian2025,
  author = {Tian, Xing and Dai, Xiaojie and Zhong, Ye and Cheng, Maosheng and Liu, Yang},
  title = {Degradation of Cyclin-Dependent Kinase: A New Weapon for Cancer Therapy},
  journal = {Pharmaceutical Fronts},
  year = {2025},
  volume = {07},
  number = {04},
  pages = {e275--e293},
  doi = {10.1055/a-2742-7859}
}
Kostenlos starten →